<div><p>The native-like, soluble SOSIP.664 trimer based on the BG505 clade A <i>env</i> gene of HIV-1 is immunogenic in various animal species, of which the most studied are rabbits and rhesus macaques. The trimer induces autologous neutralizing antibodies (NAbs) consistently but at a wide range of titers and with incompletely determined specificities. A precise delineation of immunogenic neutralization epitopes on native-like trimers could help strategies to extend the NAb response to heterologous HIV-1 strains. One autologous NAb epitope on the BG505 Env trimer is known to involve residues lining a hole in the glycan shield that is blocked by adding a glycan at either residue 241 or 289. This glycan-hole epitope accounts for the NAb respo...
Native-like trimers of the SOSIP design are being developed as immunogens in human immunodeficiency ...
Summary: Despite recent progress in engineering native trimeric HIV-1 envelope glycoprotein (Env) mi...
The high viral diversity of HIV-1 is a formidable hurdle for the development of an HIV-1 vaccine. El...
The native-like, soluble SOSIP.664 trimer based on the BG505 clade A env gene of HIV-1 is immunogeni...
The native-like, soluble SOSIP.664 trimer based on the BG505 clade A env gene of HIV-1 is immunogeni...
In HIV-1 vaccine research, native-like, soluble envelope glycoprotein SOSIP trimers are widely used ...
In HIV-1 vaccine research, native-like, soluble envelope glycoprotein SOSIP trimers are widely used ...
Extensive studies with subtype A BG505-derived HIV envelope glycoprotein (Env) immunogens have revea...
Stabilized HIV-1 envelope (Env) trimers elicit tier 2 autologous neutralizing antibody (nAb) respons...
To date, immunization studies of rabbits with the BG505 SOSIP.664 HIV envelope glycoprotein trimers ...
A major advance in the search for an HIV vaccine has been the development of a near-native Envelope ...
The human immunodeficiency virus type 1 (HIV-1) trimeric envelope glycoprotein (Env) is heavily glyc...
A major advance in the search for an HIV vaccine has been the development of a near-native Envelope ...
A major advance in the search for an HIV vaccine has been the development of a near-native Envelope ...
Recombinant soluble HIV-1 envelope glycoprotein (Env) SOSIP trimers are a design platform for induci...
Native-like trimers of the SOSIP design are being developed as immunogens in human immunodeficiency ...
Summary: Despite recent progress in engineering native trimeric HIV-1 envelope glycoprotein (Env) mi...
The high viral diversity of HIV-1 is a formidable hurdle for the development of an HIV-1 vaccine. El...
The native-like, soluble SOSIP.664 trimer based on the BG505 clade A env gene of HIV-1 is immunogeni...
The native-like, soluble SOSIP.664 trimer based on the BG505 clade A env gene of HIV-1 is immunogeni...
In HIV-1 vaccine research, native-like, soluble envelope glycoprotein SOSIP trimers are widely used ...
In HIV-1 vaccine research, native-like, soluble envelope glycoprotein SOSIP trimers are widely used ...
Extensive studies with subtype A BG505-derived HIV envelope glycoprotein (Env) immunogens have revea...
Stabilized HIV-1 envelope (Env) trimers elicit tier 2 autologous neutralizing antibody (nAb) respons...
To date, immunization studies of rabbits with the BG505 SOSIP.664 HIV envelope glycoprotein trimers ...
A major advance in the search for an HIV vaccine has been the development of a near-native Envelope ...
The human immunodeficiency virus type 1 (HIV-1) trimeric envelope glycoprotein (Env) is heavily glyc...
A major advance in the search for an HIV vaccine has been the development of a near-native Envelope ...
A major advance in the search for an HIV vaccine has been the development of a near-native Envelope ...
Recombinant soluble HIV-1 envelope glycoprotein (Env) SOSIP trimers are a design platform for induci...
Native-like trimers of the SOSIP design are being developed as immunogens in human immunodeficiency ...
Summary: Despite recent progress in engineering native trimeric HIV-1 envelope glycoprotein (Env) mi...
The high viral diversity of HIV-1 is a formidable hurdle for the development of an HIV-1 vaccine. El...